Cuprina forms joint venture company agreement with Aiodine Laboratory

Cuprina said it has signed a joint venture company agreement with Singapore-based Aiodine Laboratory to develop, test and market that company’s novel iodine-based disinfectant solution as a treatment for chronic and acute wounds, and in other common antiseptic applications. Initial applications for this iodine-based solution will focus on an antiseptic wound care formulation, disinfectants, and daily home-use antiseptics, with additional opportunities under evaluation in personal care, oral hygiene and veterinary applications. The companies plan to commence the clinical studies required to achieve regulatory approvals for these applications in 2026.